奥赛康：10月28日召开董事会会议

Group 1 - Aokang announced the convening of its seventh fifth board meeting on October 28, 2025, in Nanjing, where the agenda included the review of the third quarter report for 2025 [1] - For the year 2024, Aokang's revenue composition is 97.92% from the pharmaceutical manufacturing sector and 2.08% from other businesses [1] - As of the report, Aokang's market capitalization stands at 17.5 billion yuan [1] Group 2 - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's transformation [1]